OMGA RSI Chart
Last 7 days
-5.8%
Last 30 days
-36.3%
Last 90 days
-41.3%
Trailing 12 Months
-70.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 2.3M | 2.6M | 2.8M | 3.1M |
2022 | 626.4K | 1.1M | 1.6M | 2.1M |
2021 | 0 | 0 | 0 | 144.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 02, 2023 | young richard a | sold | -40,000 | 8.00 | -5,000 | - |
May 01, 2023 | young richard a | sold | -40,000 | 8.00 | -5,000 | - |
Apr 06, 2023 | young richard a | sold | -40,000 | 8.00 | -5,000 | - |
Mar 17, 2023 | young richard a | sold | -80,000 | 8.00 | -10,000 | - |
Feb 27, 2023 | flagship pioneering inc. | bought | 11,525,200 | 5.78 | 1,993,990 | - |
Feb 27, 2023 | flagship pioneering inc. | bought | 7,683,490 | 5.78 | 1,329,320 | - |
Jan 10, 2023 | young richard a | sold | -160,000 | 8.00 | -20,000 | - |
Sep 14, 2022 | young richard a | sold | -80,000 | 8.00 | -10,000 | - |
Feb 01, 2022 | karande mahesh | acquired | 5,989 | 0.53 | 11,300 | president and ceo |
Aug 03, 2021 | berry david a | bought | 902,394 | 17.00 | 53,082 | - |
Which funds bought or sold OMGA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Bank of New York Mellon Corp | reduced | -3.76 | 65,605 | 458,245 | -% |
Apr 25, 2024 | Zurcher Kantonalbank (Zurich Cantonalbank) | unchanged | - | 191 | 1,091 | -% |
Apr 25, 2024 | SIMPLEX TRADING, LLC | reduced | -67.94 | -5,000 | 2,000 | -% |
Apr 25, 2024 | Allworth Financial LP | sold off | -100 | -807 | - | -% |
Apr 23, 2024 | AMALGAMATED BANK | reduced | -76.17 | -7,000 | 3,000 | -% |
Apr 18, 2024 | STATE OF MICHIGAN RETIREMENT SYSTEM | unchanged | - | 201,035 | 1,146,530 | 0.01% |
Apr 18, 2024 | McGlone Suttner Wealth Management, Inc. | sold off | -100 | -19,839 | - | -% |
Apr 12, 2024 | Murphy Pohlad Asset Management LLC | unchanged | - | 10,560 | 60,225 | 0.02% |
Apr 05, 2024 | CWM, LLC | new | - | - | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 1.59 | 1,348,540 | 4,542,660 | -% |
Unveiling Omega Therapeutics, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Omega Therapeutics, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 41.2B | 6.8B | -8.75 | 6.02 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.0B | 1.8B | -41 | 9.87 | ||||
BMRN | 15.4B | 2.5B | 74.73 | 6.21 | ||||
INCY | 11.6B | 3.7B | 19.41 | 3.14 | ||||
MID-CAP | ||||||||
APLS | 6.0B | 396.6M | -11.37 | 15.16 | ||||
BBIO | 4.4B | - | -6.7 | 60.35 | ||||
AXSM | 3.4B | 270.6M | -14.22 | 12.57 | ||||
ACAD | 2.8B | 726.4M | -44.9 | 3.79 | ||||
ARWR | 2.7B | 240.7M | -9.23 | 12.18 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 24.58 | 4.41 | ||||
NVAX | 569.6M | 983.7M | -1.05 | 0.58 | ||||
CRBP | 361.2M | 881.7K | -8.1 | 466.16 | ||||
INO | 247.0M | 4.9M | -1.83 | 50.76 | ||||
IBIO | 6.1M | 2.1M | -0.22 | 2.14 |
Omega Therapeutics, Inc. News
Income Statement (Quarterly) | ||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 19.0% | 989 | 831 | 759 | 516 | 735 | 595 | 476 | 268 | - |
Operating Expenses | -8.6% | 21,688 | 23,734 | 31,599 | 26,334 | 31,702 | 26,580 | 26,330 | 20,227 | 20,808 |
S&GA Expenses | -21.8% | 6,157 | 7,869 | 6,206 | 5,954 | 7,036 | 5,198 | 6,202 | 5,406 | 5,727 |
R&D Expenses | -4.6% | 15,715 | 16,475 | 25,012 | 19,968 | 26,879 | 20,670 | 19,387 | 14,191 | 14,644 |
Interest Expenses | -28.8% | 487 | 684 | 957 | 682 | 248 | 184 | -55.00 | -155 | -571 |
Net Income | 9.1% | -20,214 | -22,248 | -29,687 | -25,279 | -30,826 | -25,799 | -25,912 | -20,164 | -20,854 |
Net Income Margin | 17.2% | -31.48* | -38.04* | -42.85* | -46.44* | -49.53* | -58.28* | -77.08* | -119.67* | -474.17* |
Free Cashflow | 23.2% | -18,211 | -23,724 | -23,564 | -28,403 | -24,529 | -25,163 | -26,701 | -23,502 | -16,156 |
Balance Sheet | |||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | -6.2% | 204 | 218 | 229 | 156 | 146 | 170 | 193 | 217 | 233 | 243 | 130 | 28.00 |
Current Assets | -11.8% | 90.00 | 102 | 125 | 149 | 138 | 161 | 183 | 206 | 229 | 239 | 125 | 24.00 |
Cash Equivalents | -16.3% | 68.00 | 82.00 | 106 | 105 | 71.00 | 77.00 | 91.00 | 106 | 186 | 234 | 122 | 23.00 |
Net PPE | -0.8% | 5.00 | 5.00 | 6.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 |
Liabilities | 3.2% | 146 | 142 | 133 | 33.00 | 40.00 | 36.00 | 36.00 | 36.00 | 33.00 | 23.00 | 22.00 | 17.00 |
Current Liabilities | 0.0% | 27.00 | 27.00 | 34.00 | 18.00 | 22.00 | 15.00 | 14.00 | 14.00 | 12.00 | 14.00 | 12.00 | 8.00 |
Long Term Debt | -6.2% | 15.00 | 16.00 | 12.00 | 14.00 | 17.00 | 20.00 | 20.00 | 20.00 | 20.00 | 7.00 | 9.00 | 9.00 |
LT Debt, Current | 0% | 4.00 | 4.00 | 8.00 | 6.00 | 3.00 | - | - | - | - | 5.00 | 3.00 | 3.00 |
LT Debt, Non Current | -6.2% | 15.00 | 16.00 | 12.00 | 14.00 | 17.00 | 20.00 | 20.00 | 20.00 | 20.00 | 7.00 | 9.00 | 9.00 |
Shareholder's Equity | -23.7% | 58.00 | 76.00 | 96.00 | 123 | 106 | 134 | 157 | 181 | 201 | 220 | - | - |
Retained Earnings | -6.4% | -334 | -314 | -292 | -262 | -237 | -206 | -180 | -154 | -134 | -113 | -95.12 | -66.22 |
Additional Paid-In Capital | 0.5% | 393 | 390 | 388 | 386 | 344 | 341 | 339 | 337 | 335 | 334 | 3.00 | 2.00 |
Shares Outstanding | 0.0% | 55.00 | 55.00 | 55.00 | 55.00 | 48.00 | 48.00 | 48.00 | 48.00 | 48.00 | 14.00 | 5.00 | 4.00 |
Float | - | - | - | 140 | - | - | - | 80.00 | - | - | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | 25.7% | -17,100 | -23,000 | -23,289 | -28,111 | -24,237 | -24,835 | -26,093 | -23,350 | -15,956 | -16,496 | -14,608 | -10,549 | - | - | - |
Share Based Compensation | -7.3% | 2,113 | 2,280 | 2,178 | 2,222 | 2,122 | 1,974 | 2,053 | 1,604 | 1,182 | 1,123 | 685 | 194 | - | - | - |
Cashflow From Investing | 395.6% | 2,140 | -724 | 24,049 | 22,050 | 17,652 | 10,588 | 11,267 | -57,567 | -39,132 | -353 | -866 | -48.00 | - | - | - |
Cashflow From Financing | 20412.5% | 1,625 | -8.00 | 219 | 39,987 | 586 | 4.00 | 35.00 | 83.00 | 7,295 | 128,713 | 118 | 125,413 | - | - | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
Collaboration revenue from related party | $ 3,094 | $ 2,073 |
Operating expenses: | ||
Research and development | 77,169 | 81,167 |
General and administrative | 26,186 | 23,672 |
Total operating expenses | 103,355 | 104,839 |
Loss from operations | (100,261) | (102,766) |
Other Income (expense), net: | ||
Interest income, net | 2,810 | 222 |
Other income (expense), net | 23 | (157) |
Total other income, net | 2,833 | 65 |
Net loss | $ (97,428) | $ (102,701) |
Net loss per common stock attributable to common stockholders, basic | $ (1.8) | $ (2.14) |
Net loss per common stock attributable to common stockholders, diluted | $ (1.8) | $ (2.14) |
Weighted-average common stock used in net loss per share attributable to common stockholders, basic | 54,010,996 | 47,880,819 |
Weighted-average common stock used in net loss per share attributable to common stockholders, diluted | 54,010,996 | 47,880,819 |
Comprehensive loss: | ||
Net Income (Loss) | $ (97,428) | $ (102,701) |
Other comprehensive income (loss): | ||
Unrealized gain (loss) on marketable securities | 465 | (417) |
Comprehensive loss | $ (96,963) | $ (103,118) |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 68,443 | $ 70,615 |
Marketable securities | 4,986 | 54,063 |
Accounts receivable, due from related party | 1,006 | 618 |
Accounts receivable | 5,125 | |
Prepaid expenses and other current assets | 10,324 | 12,294 |
Total current assets | 89,884 | 137,590 |
Property and equipment, net | 5,311 | 4,195 |
Operating lease right-of-use assets, net | 108,736 | 3,668 |
Restricted cash | 341 | 341 |
Other assets | 94 | 204 |
Total assets | 204,366 | 145,998 |
Current liabilities: | ||
Accounts payable | 1,620 | 3,107 |
Accrued expenses | 7,914 | 13,841 |
Other current liabilities | 1,972 | 159 |
Lease liabilities, current | 11,300 | 1,524 |
Long-term debt, current portion | 4,000 | 3,333 |
Total current liabilities | 26,806 | 21,964 |
Lease liabilities, non-current | 98,243 | 1,120 |
Long-term debt, net | 14,885 | 16,603 |
Other liabilities | 6,416 | 340 |
Total liabilities | 146,350 | 40,027 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value; 10,000,000 shares authorized as of December 31, 2023 and December 31, 2022; no shares issued and outstanding as of December 31, 2023 and December 31, 2022 | 0 | 0 |
Common stock, $0.001 par value; 200,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 55,144,982 and 48,072,517 issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 55 | 48 |
Additional paid-in capital | 392,609 | 343,608 |
Accumulated other comprehensive loss | (14) | (479) |
Accumulated deficit | (334,634) | (237,206) |
Total stockholders' equity | 58,016 | 105,971 |
Total liabilities and stockholders' equity | $ 204,366 | $ 145,998 |